These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 34940)
1. [Inhibition of blood platelet function]. Glusa E Z Gesamte Inn Med; 1979 Jan; 34(1):17-22. PubMed ID: 34940 [TBL] [Abstract][Full Text] [Related]
2. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents]. Jobin F Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662 [No Abstract] [Full Text] [Related]
3. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
4. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
5. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits. Arfors KE; Bergqvist D; Tangen O Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111 [TBL] [Abstract][Full Text] [Related]
8. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood. Baumgartner HR Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014 [TBL] [Abstract][Full Text] [Related]
9. [Antiaggregants of thrombocytes in ischemic heart disease]. Beloev I ; Tomov I; TŭrnovskaR Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572 [No Abstract] [Full Text] [Related]
10. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. Oelz O Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707 [TBL] [Abstract][Full Text] [Related]
11. Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding. de Gaetano G; Donati MB; Garattini S Thromb Diath Haemorrh; 1975 Sep; 34(1):285-303. PubMed ID: 1081280 [No Abstract] [Full Text] [Related]
12. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium? Hladovec J Thromb Haemost; 1979 Jun; 41(4):474-8. PubMed ID: 483235 [TBL] [Abstract][Full Text] [Related]
13. Platelet inhibitor therapy. Agents and clinical implications. Webster MW; Chesebro JH; Fuster V Hematol Oncol Clin North Am; 1990 Feb; 4(1):265-89. PubMed ID: 2179212 [TBL] [Abstract][Full Text] [Related]
15. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Buchanan M; Hirsh J Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423 [No Abstract] [Full Text] [Related]
16. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation]. Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074 [No Abstract] [Full Text] [Related]
17. [Indications and uncertainties of antiaggregating agents]. Verstraete M Rev Prat; 1977 Dec; 27(57):3999-4005. PubMed ID: 345400 [No Abstract] [Full Text] [Related]
18. Pharmacological properties of drug inhibiting platelet aggregation. de Gaetano G Acta Clin Belg; 1975; 30(3):184-9. PubMed ID: 1231456 [No Abstract] [Full Text] [Related]
19. The retired breeder rat as a new model for antiplatelet drug discovery. Saunders RN; Burns TS; Stelzer MR; Waskawic ER Lab Anim Sci; 1977 Oct; 27(5 Pt 2):757-61. PubMed ID: 592727 [TBL] [Abstract][Full Text] [Related]
20. [Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy]. Fernández B de Quirós J; Dulp-Gollasch I; Hess H Rev Clin Esp; 1978 Nov; 151(3):219-22. PubMed ID: 740996 [No Abstract] [Full Text] [Related] [Next] [New Search]